ORBIMED ADVISORS LLC 13D and 13G filings for SpringWorks Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-06 4:43 pm Sale |
2023-12-04 | 13D | SpringWorks Therapeutics, Inc. SWTX |
ORBIMED ADVISORS LLC | 3,567,159 4.900% |
-611,429 (-14.63%) |
Filing |
| 2023-05-17 4:46 pm Sale |
2023-05-15 | 13D | SpringWorks Therapeutics, Inc. SWTX |
ORBIMED ADVISORS LLC | 4,178,588 6.700% |
-806,412 (-16.18%) |
Filing |
| 2023-01-05 4:40 pm Sale |
2023-01-03 | 13D | SpringWorks Therapeutics, Inc. SWTX |
ORBIMED ADVISORS LLC | 4,985,000 8.000% |
-614,842 (-10.98%) |
Filing |
| 2022-09-14 4:34 pm Sale |
2022-09-12 | 13D | SpringWorks Therapeutics, Inc. SWTX |
ORBIMED ADVISORS LLC | 5,599,842 9.300% |
-586,465 (-9.48%) |
Filing |
| 2021-03-03 6:50 pm Sale |
2021-03-01 | 13D | SpringWorks Therapeutics, Inc. SWTX |
ORBIMED ADVISORS LLC | 6,186,307 12.600% |
-1,220,000 (-16.47%) |
Filing |
| 2020-10-13 9:14 pm Unchanged |
2020-10-13 | 13D | SpringWorks Therapeutics, Inc. SWTX |
ORBIMED ADVISORS LLC | 7,406,307 15.500% |
0 (Unchanged) |
Filing |